{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:18:10Z","timestamp":1787620690893,"version":"build-2736575974"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,28]]},"DOI":"10.1093\/ecco-jcc\/jjy122","type":"journal-article","created":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T07:10:47Z","timestamp":1535267447000},"page":"1410-1417","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal Strategies"],"prefix":"10.1093","volume":"12","author":[{"given":"Shomron","family":"Ben-Horin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"},{"name":"Department of Gastroenterology, First Affiliated Hospital, Sun YatSen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Van Assche","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University Hospitals Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Chowers","sequence":"additional","affiliation":[{"name":"Rambam Health Care Campus & Bruce Rappaport School of Medicine, Technion Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Fudim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella","family":"Ungar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Picard","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Yavzori","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Kopylov","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, First Affiliated Hospital, Sun YatSen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-hu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, First Affiliated Hospital, Sun YatSen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Peled","sequence":"additional","affiliation":[{"name":"The Olga and Lev Leviev Heart Center, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Gueta","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Sheba Medical Center Tel Hashomer, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Eliakim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Loebstein","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Markovits","sequence":"additional","affiliation":[{"name":"The Institute of Clinical Pharmacology, Sheba Medical Center Tel Hashomer & Sackler School of Medicine, Tel-Aviv University, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"key\n\t\t\t\t2018112810271013600_CIT0001","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11938-017-0128-0","article-title":"Thiopurines and methotrexate use in IBD patients in a biologic era","volume":"15","author":"Mantzaris","year":"2017","journal-title":"Curr Treat Options Gastroenterol"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0002","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1046\/j.1365-2036.2001.01102.x","article-title":"Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine","volume":"15","author":"Nielsen","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0003","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0004","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0005","doi-asserted-by":"crossref","first-page":"13699","DOI":"10.1074\/jbc.M115.694422","article-title":"Thiopurine prodrugs mediate immunosuppressive effects by interfering with Rac1 protein function","volume":"291","author":"Shin","year":"2016","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0006","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2125.1995.tb05776.x","article-title":"The accumulation of mercaptopurine metabolites in age fractionated red blood cells","volume":"40","author":"Rostami-Hodjegan","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.2010.320","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1043-6618(02)00264-5","article-title":"Azathioprine and anti-TNF alpha therapies in Crohn\u2019s disease: a review of pharmacology, clinical efficacy and safety","volume":"47","author":"Arnott","year":"2003","journal-title":"Pharmacol Res"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","article-title":"Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis","volume":"123","author":"Pearson","year":"1995","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0010","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/gut.2008.157339","article-title":"Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines","volume":"58","author":"Ben-Horin","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0011","first-page":"540","article-title":"Vaccinating patients with inflammatory bowel disease","volume":"12","author":"Reich","year":"2016","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0012","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0013","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/MIB.0000000000000002","article-title":"Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops","volume":"20","author":"Swoger","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0014","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2014.07.027","article-title":"Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn\u2019s disease","volume":"13","author":"Drobne","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0015","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.4049\/jimmunol.170.10.4986","article-title":"Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides","volume":"170","author":"Qu\u00e9m\u00e9neur","year":"2003","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0016","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1053\/j.gastro.2008.03.004","article-title":"Withdrawal of immunosuppression in Crohn\u2019s disease treated with scheduled infliximab maintenance: a randomized trial","volume":"134","author":"Van Assche","year":"2008","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0017","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1542-3565(04)00238-1","article-title":"Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn\u2019s disease","volume":"2","author":"Hanauer","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0018","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gut.2006.099978","article-title":"Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn\u2019s disease","volume":"56","author":"Vermeire","year":"2007","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0019","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/gutjnl-2013-305259","article-title":"The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab","volume":"63","author":"Ungar","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2011.09.034","article-title":"Maintenance of remission among patients with Crohn\u2019s disease on antimetabolite therapy after infliximab therapy is stopped","volume":"142","author":"Louis","year":"2012","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0021","article-title":"Outcome of elective withdrawal of anti-tumour necrosis factor-\u03b1 therapy in patients with Crohn\u2019s disease in established remission","author":"Brooks","year":"2015","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0022","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/apt.13268","article-title":"Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal","volume":"42","author":"Ben-Horin","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.2011.04905.x","article-title":"Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease","volume":"35","author":"Chouchana","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0024","first-page":"1","article-title":"Purine metabolism of the human erythrocyte","volume":"19","author":"Micheli","year":"1983","journal-title":"Quad Sclavo Diagn"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.leukres.2007.09.015","article-title":"Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine","volume":"32","author":"Peng","year":"2008","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0026","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1751-2980.2011.00556.x","article-title":"6-Mercaptopurine transport in human lymphocytes: correlation with drug-induced cytotoxicity","volume":"13","author":"Conklin","year":"2012","journal-title":"J Dig Dis"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0027","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1124\/mol.62.6.1321","article-title":"Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells","volume":"62","author":"Wielinga","year":"2002","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0028","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1046\/j.1432-1033.2003.03753.x","article-title":"cGMP and glutathione-conjugate transport in human erythrocytes","volume":"270","author":"Klokouzas","year":"2003","journal-title":"Eur J Biochem"},{"key":"key\n\t\t\t\t2018112810271013600_CIT0029","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1063-5823(03)01013-5","article-title":"ATP in the treatment of advanced cancer","volume":"54","author":"Abraham","year":"2003","journal-title":"Current Topics in Membranes"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/12\/12\/1410\/26770394\/jjy122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T20:04:16Z","timestamp":1571774656000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/12\/1410\/5085991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,8,27]]},"published-print":{"date-parts":[[2018,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy122","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,8,27]]}}}